Preanesthesia medical evaluation for electroconvulsive therapy: A review of the literature

Journal of ECT

Volumn 30, Issue 1, 2014, Pages 35-42

  Sundsted, Karna K ^a   Burton, Mary Caroline ^a   Shah, Riddhi ^a   Lapid, Maria I ^b  

^a Information Technology   (United States)

^b MAYO CLINIC   (United States)

Author keywords

comorbidity; medical assessment; pre ECT evaluation

Indexed keywords

ADULT; AGED; ALGORITHMS; ANESTHESIA; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; COMORBIDITY; DIABETES COMPLICATIONS; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; KIDNEY DISEASES; LUNG DISEASES; MALE; MENTAL DISORDERS; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PREGNANCY;

EID: 84894469316     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e3182a3546f     Document Type: Conference Paper

References (56)

1. Rabheru K. The use of electroconvulsive therapy in special patient populations. Can J Psychiatry. 2001;46:710-719.
2. Tess AV, Smetana GW. Medical evaluation of patients undergoing electroconvulsive therapy. N Engl J Med. 2009;360:1437-1444.
3. Watts BV, Groft A, Bagian JP, et al. An examination of mortality and other adverse events related to electroconvulsive therapy using a national adverse event report system. J ECT. 2011; 27:105-108.
4. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: executive Summary: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. [Erratum appears in J Am Coll Cardiol. 2008 Aug 26;52(9):794-797 Note: Chaikof, Elliott [corrected to Chaikof, Elliott L]]. J Am Coll Cardiol. 2007;50:1707-1732.
5. Cristancho MA, Alici Y, Augoustides JG, et al. Uncommon but serious complications associated with electroconvulsive therapy: recognition and management for the clinician. Curr Psychiatry Rep. 2008;10:474-480.
6. Lafferty JE, North CS, Spitznagel E, et al. Laboratory screening prior to ECT. J ECT. 2001;17:158-165.
7. American Psychiatric Association Committee on Electroconvulsive Therapy,Weiner RD. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging (A Task Force Report of the American Psychiatric Association). 2nd Edition. Washington DC: American Psychiatric Press; 2001.
8. Milstein V, Milstein MJ, Small IF. Radiographic screening for ECT: use and usefulness. Convuls Ther. 1995;11:38-44.
9. Wieck A, Gregoire A. Drugs, hormones and ECT in childbearing women with psychiatric disorders. Psychiatry. 2006;5:25-38.
10. Flint AJ, Gagnon N. Effective use of electroconvulsive therapy in late-life depression. Can J Psychiatry. 2002;47:734-741.
11. van Schaik AM, Comijs HC, Sonnenberg CM, et al. Efficacy and safety of continuation and maintenance electroconvulsive therapy in depressed elderly patients: a systematic review. Am J Geriatr Psychiatr. 2012;20:5-17.
12. van der Wurff FB, Stek ML, Hoogendijk WJ, et al. The efficacy and safety of ECT in depressed older adults: a literature review. Int J Geriatr Psychiatry. 2003;18:894-904.
13. Wilkinson AW, Anderson DN, Peters S. Age and the effects of ECT. Int J Geriatr Psychiatry. 1993;8:401-406.
14. Zervas IM, Calev A, Jandorf L, et al. Age-dependent effects of electroconvulsive therapy on memory. Convuls Ther. 1993;9:39-42.
15. Rao SS, Daly JW, Sewell DD. Falls associated with electroconvulsive therapy among the geriatric population: a case report. J ECT. 2008;24:173-175.
16. Christopher EJ. Electroconvulsive therapy in the medically ill. Curr Psychiatry Rep. 2003;5:225-230.
17. Mehta V, Mueller PS, Gonzalez-Arriaza HL, et al. Safety of electroconvulsive therapy in patients receiving long-term warfarin therapy. Mayo Clin Proc. 2004;79:1396-1401.
18. Rice EH, Sombrotto LB, Markowitz JC, et al. Cardiovascular morbidity in high-risk patients during ECT. Am J Psychiatry. 1994;151:1637-1641.
19. Nuttall GA, Bowersox MR, Douglass SB, et al. Morbidity and mortality in the use of electroconvulsive therapy. J ECT. 2004; 20:237-241.
20. Magid M, Lapid MI, Sampson SM, et al. Use of electroconvulsive therapy in a patient 10 days after myocardial infarction. J ECT. 2005;21:182-185.
21. Aloysi AS, Maloutas E, Gomes A, et al. Safe resumption of electroconvulsive therapy after non-ST segment elevation myocardial infarction. J ECT. 2011;27:e39-e41.
22. Rasmussen KG, Rummans TA, Richardson JW. Electroconvulsive therapy in the medically ill. Psychiatr Clin North Am. 2002; 25:177-193.
23. Fletcher GF, Balady G, Froelicher VF, et al. Exercise standards. A statement for healthcare professionals from the American Heart Association. Writing Group. Circulation. 1995;91:580-615.
24. Rivera FA, Lapid MI, Sampson S, et al. Safety of electroconvulsive therapy in patients with a history of heart failure and decreased left ventricular systolic heart function. J ECT. 2011;27:207-213.
25. McCully RB, Karon BL, Rummans TA, et al. Frequency of left ventricular dysfunction after electroconvulsive therapy. Am J Cardiol. 2003;91:1147-1150.
26. Rasmussen KG. Electroconvulsive therapy in patients with aortic stenosis. Convuls Ther. 1997;13:196-199.
27. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118:e523-e661.
28. Mueller PS, Barnes RD, Varghese R, et al. The safety of electroconvulsive therapy in patients with severe aortic stenosis. Mayo Clin Proc. 2007;82:1360-1363.
29. Sutor B, Mueller PS, Rasmussen KG. Bradycardia and hypotension in a patient with severe aortic stenosis receiving electroconvulsive therapy dose titration for treatment of depression. J ECT. 2008; 24:281-282.
30. O'Reardon JP, Cristancho MA, Ryley B, et al. Electroconvulsive therapy for treatment of major depression in a 100-year-old patient with severe aortic stenosis: a 5-year follow-up report. J ECT. 2011;27:227-230.
31. Pullen SJ, Rasmussen KG, Angstman ER, et al. The safety of electroconvulsive therapy in patients with prolonged QTc intervals on the electrocardiogram. J ECT. 2011;27:192-200.
32. Petrides G, Fink M. Atrial fibrillation, anticoagulation, and electroconvulsive therapy. Convuls Ther. 1996;12:91-98.
33. Dolenc TJ, Barnes RD, Hayes DL, et al. Electroconvulsive therapy in patients with cardiac pacemakers and implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2004;27:1257-1263.
34. Lapid MI, Rummans TA, Hofmann VE, et al. ECT and automatic internal cardioverter-defibrillator. J ECT. 2001;17:146-148.
35. Kokras N, Politis AM, Zervas IM, et al. Cardiac rhythm management devices and electroconvulsive therapy: a critical review apropos of a depressed patient with a pacemaker. J ECT. 2011;27:214-220.
36. Davis A, Zisselman M, Simmons T, et al. Electroconvulsive therapy in the setting of implantable cardioverter-defibrillators. J ECT. 2009;25:198-201.
37. Pornnoppadol C, Isenberg K. ECT with implantable cardioverter defibrillator. J ECT. 1998;14:124-126.
38. Bourke ME. The patient with a pacemaker or related device. Can J Anaesth. 1996;43(5 Pt 2):R24-R41.
39. Giltay EJ, Kho KH, Keijzer LT, et al. Electroconvulsive therapy (ECT) in a patient with a dual-chamber sensing, VDDR pacemaker. J ECT. 2005;21:35-38.
40. MacPherson RD, Loo CK, Barrett N. Electroconvulsive therapy in patients with cardiac pacemakers. Anaesth Intensive Care. 2006; 34:470-474.
41. American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Rhythm Management Devices. Practice advisory for the perioperative management of patients with cardiac rhythm management devices: pacemakers and implantable cardioverter-defibrillators: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Rhythm Management Devices. Anesthesiology. 2005; 103:186-198.
42. Mueller PS, Albin SM, Barnes RD, et al. Safety of electroconvulsive therapy in patients with unrepaired abdominal aortic aneurysm: report of 8 patients. J ECT. 2009;25:165-169.
43. Fleming C, Whitlock EP, Beil TL, et al. Screening for abdominal aortic aneurysm: a best-evidence systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2005;142:203-211.
44. Weintraub D, Lippmann SB. Electroconvulsive therapy in the acute poststroke period. J ECT. 2000;16:415-418.
45. Martin M, Figiel G, Mattingly G, et al. ECT-induced interictal delirium in patients with a history of a CVA. J Geriatr Psychiatry Neurol. 1992;5:149-155.
46. Murray GB, Shea V, Conn DK. Electroconvulsive therapy for poststroke depression. J Clin Psychiatry. 1986;47:258-260.
47. Kang N, Passmore MJ. Successful ECT in a patient with an orbital cavernous hemangioma. J ECT. 2004;20:267-271.
48. Bader GM, Silk KR, Dequardo JR, et al. Electroconvulsive therapy and intracranial aneurysm. Convuls Ther. 1995;11:139-143.
49. Maltbie AA, Wingfield MS, Volow MR, et al. Electroconvulsive therapy in the presence of brain tumor. Case reports and an evaluation of risk. J Nerv Ment Dis. 1980;168:400-405.
50. Bailine S, Kremen N, Kohen I, et al. Bitemporal electroconvulsive therapy for depression in a Parkinson disease patient with a deep-brain stimulator. J ECT. 2008;24:171-172.
51. Fitzsimons MG, Welch CA, Haspel KL, et al. The safety and efficacy of ECT and anesthesia in the setting of multiple sclerosis. J Psychiatr Pract. 2007;13:195-198.
52. Schak KM, Mueller PS, Barnes RD, et al. The safety of ECT in patients with chronic obstructive pulmonary disease. Psychosomatics. 2008;49:208-211.
53. Mueller PS, Schak KM, Barnes RD, et al. Safety of electroconvulsive therapy in patients with asthma. Neth J Med. 2006;64:417-421.
54. Suzuki K, Takamatsu K, Takano T, et al. Safety of electroconvulsive therapy in psychiatric patients shortly after the occurrence of pulmonary embolism. J ECT. 2008;24:286-288.
55. Wille PD. Electroconvulsive therapy in a patient on chronic hemodialysis. Nephrol Nurs J. 2007;34:441-443.
56. Netzel PJ, Mueller PS, Rummans TA, et al. Safety, efficacy, and effects on glycemic control of electroconvulsive therapy in insulin-requiring type 2 diabetic patients. J ECT. 2002;18:16-21.